“Boehringer has had a successful year as one of the leading research investors in the industry. Our impressive pipeline is coming together nicely, with many contributions from clinical trial sites in Australia and New Zealand," said Dirk Otto, the general manager of Boehringer Ingelheim Australia and New Zealand.
'We celebrate our 60th anniversary in Australia, I am extremely optimistic about the next 60'
April 17, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
Summit's day one provided critical lessons for both sides of the Tasman
April 30, 2024 - - Latest News -
'Important for me to share the full picture as we must never allow it to happen again'
April 30, 2024 - - Latest News -
NZ Government commits new funding to address Pharmac's 'fiscal cliff'
April 29, 2024 - - Latest News -
NZ Government appoints former Deputy PM new chair of Pharmac
April 29, 2024 - - Latest News -
The listing will 'benefit thousands of Australian women', says Mark Butler
April 29, 2024 - - Latest News -
'An important first step to achieving reimbursed access for eligible patients in Australia'
April 28, 2024 - - Latest News -
The 'Week in Review' Podcast - 26 April
April 28, 2024 - - Podcast